Does UnitedHealthcare Cover Weight Loss Treatment in Texas? A 2026 Guide

Last updated: August 31, 2026

UnitedHealthcare commercial plans in Texas may cover some obesity and weight-loss care, but GLP-1 coverage typically depends on the OptumRx prescription drug list, prior authorization, BMI criteria, and whether the plan excludes weight-loss drugs. Mental health parity (MHPAEA and Texas Insurance Code Chapter 1355) does not force a commercial plan to cover anti-obesity medication. Coverage varies by employer group and individual plan. Verify benefits before you book.

See if you may qualify for online weight-loss care with licensed providers in Klarity Health’s 2,000+ network, or browse conditions we treat.

TLDR

• UnitedHealthcare Texas commercial pharmacy is typically OptumRx, not CVS/Caremark and not Cigna Express Scripts.
• Wegovy, Zepbound, phentermine, Qsymia, Contrave, and orlistat may sit on different tiers or be excluded. Your specific PDL controls.
• CVS/Caremark’s July 1, 2025 Zepbound removal and October 1, 2026 reinstatement apply to many Aetna plans, not typical UHC OptumRx formularies.
• Cigna PA Policy IP0477 (stimulants) is a Cigna rule. Do not treat it as UnitedHealthcare policy.
• Phentermine and Qsymia are Schedule IV. GLP-1s, Contrave, and orlistat are typically unscheduled. HHS/DEA telemedicine flexibilities for controlled medications run through December 31, 2026 ([DEA](https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care)).
• Texas telehealth for commercial health plans: Insurance Code Chapter 1455.
• UnitedHealthcare Medicare Advantage and Texas Medicaid STAR/CHIP follow different rules than commercial UHC. Medicare GLP-1 Bridge ($50/month Wegovy, Zepbound KwikPen, Foundayo from July 1, 2026 through December 31, 2027) is a CMS program, not an OptumRx commercial benefit ([CMS](https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge)).
• TDI consumer Help Line: 1-800-252-3439 ([TDI](https://www.tdi.texas.gov/consumer/get-help-with-an-insurance-complaint.html)). Medicare Advantage appeals often go to Maximus IRE at 1-855-887-6668.

If you are in crisis, call or text 988.

Does UnitedHealthcare cover weight loss treatment in Texas?

Often, some pieces of care may be covered and others may not. A video visit with a licensed clinician, labs, and counseling for obesity-related conditions may process under medical benefits. Anti-obesity drugs frequently sit on the pharmacy benefit with prior authorization, step therapy, quantity limits, or a plan exclusion.

Check three documents: your Summary of Benefits, the medical policy for obesity or bariatric services, and the current OptumRx PDL for your group. UnitedHealthcare publishes plan PDLs at uhc.com prescription drug lists.

Related Texas UHC guides: ADHD, anxiety, and depression. An earlier overview also lives at UnitedHealthcare Texas Weight Loss Treatment Coverage.

OptumRx vs Caremark and Express Scripts

UnitedHealthcare commercial members in Texas typically use OptumRx. That matters because 2025-2026 GLP-1 headlines often mix PBMs:

• CVS/Caremark Zepbound timeline (removed July 1, 2025; reinstated October 1, 2026 on many Caremark lists) is an Aetna/Caremark story, not default UHC.
• Cigna/ESI did not follow that Caremark removal for Zepbound on many lists (often Tier 3-4). Still not UHC.
• IP0477 is Cigna’s stimulant prior-authorization policy (effective May 15, 2026). It does not govern UnitedHealthcare ADHD or weight-loss drugs.

Ask the pharmacy which PBM adjudicates the claim. If the card says OptumRx, use that PDL.

Verify whether online weight-loss care may fit your plan.

GLP-1s and other weight-loss medications

Plans may treat FDA-labeled obesity drugs differently from diabetes-labeled GLP-1s used off-label. Common Texas commercial patterns (always confirm on your list):

• Wegovy (semaglutide) and Zepbound (tirzepatide): often PA, BMI plus comorbidity criteria, and sometimes exclusion on leaner employer plans.
• Ozempic / Mounjaro: typically labeled for type 2 diabetes. Many plans deny obesity-only use.
• Contrave and orlistat (Xenical/Alli): usually unscheduled; coverage still varies.
• Phentermine and Qsymia: Schedule IV. Texas PDMP and federal controlled-substance rules apply. Telehealth prescribing of controlled medications remains under HHS/DEA flexibilities through December 31, 2026 ([Federal Register](https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled)).

Parity law does not convert an excluded anti-obesity drug into a covered mental-health benefit. Chapter 1355 addresses serious mental illness coverage on applicable Texas plans. It is not a GLP-1 mandate.

Telehealth in Texas

Texas Insurance Code Chapter 1455 generally requires applicable commercial plans to cover telemedicine and telehealth services on the same basis as in-person care when the service is otherwise a covered benefit. It does not create a new drug benefit. A visit that would be covered in clinic may typically be covered by video when the clinician is licensed in Texas and the code is eligible.

Klarity Health connects Texas patients with licensed clinicians for evaluation and, when appropriate, prescription management. We do not promise that UnitedHealthcare will pay any specific claim.

Medicare Advantage, STAR, and dual-eligible notes

Many Texans carry UnitedHealthcare Medicare Advantage or Medicaid STAR, not a commercial large-group PPO. Those products follow CMS and Texas HHSC rules.

Starting July 1, 2026, the Medicare GLP-1 Bridge offers eligible Medicare beneficiaries selected GLP-1s (Wegovy injection or tablet, Zepbound KwikPen, Foundayo tablet) at $50 per month through December 31, 2027, outside typical Part D weight-loss exclusions ([CMS press release](https://www.cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries); [Medicare.gov](https://www.medicare.gov/coverage/weight-loss-drugs)). That is a federal demonstration, not an OptumRx commercial formulary change.

Medicaid and dual-eligible members should confirm STAR/CHIP pharmacy, not a commercial PDL. TDI does not rewrite federal Medicare Advantage contracts. MA appeals typically use the plan’s reconsideration process, then Maximus IRE at 1-855-887-6668.

How to check your UnitedHealthcare Texas plan

1. Log in to myuhc.com or the UnitedHealthcare app and open pharmacy benefits.
2. Search Wegovy, Zepbound, phentermine, Contrave, or orlistat on your exact PDL.
3. Call the number on your card and ask about PA, step therapy, and obesity exclusions.
4. If a commercial claim is denied and you believe Texas law applies, TDI Help Line is 1-800-252-3439.

Bring BMI history, comorbidity notes, and prior medication trials. Incomplete PA packets often delay or deny GLP-1 requests.

How Klarity Health can help

Klarity Health’s 2,000+ licensed providers offer online evaluations for weight management and related conditions. A visit can review history, discuss medication options when clinically appropriate, and document what your insurer typically asks for. Coverage still varies. Check benefits first.

See if you may qualify · Explore conditions

FAQ

Does UnitedHealthcare in Texas cover Wegovy or Zepbound for weight loss?

It may, on some commercial OptumRx lists with prior authorization. Other groups exclude anti-obesity drugs. Confirm on your PDL. Do not assume Caremark’s 2025-2026 Zepbound timeline applies to UHC.

Does Texas parity force UHC to cover GLP-1s?

No. MHPAEA and Chapter 1355 address mental-health and SUD benefits. They do not require commercial coverage of obesity medication.

Can a Texas clinician prescribe phentermine by telehealth in 2026?

Schedule IV phentermine may be prescribed via telemedicine under current HHS/DEA flexibilities through December 31, 2026, subject to Texas licensure, PDMP, and medical necessity. Unscheduled GLP-1s follow ordinary prescribing rules, not that controlled-substance waiver.

What if I have UHC Medicare Advantage in Texas?

Ask about Part D versus the Medicare GLP-1 Bridge. TDI commercial complaint tools generally do not control MA. Use plan appeals and, when applicable, Maximus IRE 1-855-887-6668.

This article is educational, not medical or insurance advice. Coverage varies by plan. Verify benefits before booking. If you are in crisis, call or text 988.